Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Neumedicines Inc.
Angimmune LLC
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Florida Academic Dermatology Centers
National Cancer Institute (NCI)